INDUSTRY NEWS

First Study Identifies Risk Factors Associated With Death in Adults Hospitalized With New Coronavirus Disease in Wuhan

Being of an older age, showing signs of sepsis, and having blood clotting issues when admitted to hospital are key risk factors associated with higher risk of death from the new coronavirus (COVID-19), according to a new observational study of 191 patients with confirmed COVID-19 from two hospitals in Wuhan, China. Journal Reference: Fei Zhou, Ting Yu, Ronghui Du, MD, et al. Clinical course and risk factors for mortality of adult...

CVD in the Setting of COVID-19: Considerations to Prepare Patients, Providers, Health Systems

The cardiovascular community will be on the frontlines and play a key role in managing and treating patients with COVID-19. In a paper published March 19 in the Journal of the American College of Cardiology, considerations for patients, providers and health systems now and during the COVID-19 pandemic are outlined, along with a review of what's currently known from the available literature about this disease and its cardiovascular impacts, as well...

Cardiac Considerations Amid COVID-19: Shared Stories May Save Lives

The experience of Chinese physicians is leading the way for others around the world as the pandemic explodes in the US. As the medical community mobilizes to deal with growing infection rates of COVID-19, physicians are trying to understand how the virus interacts with the cardiovascular system, taking cues from the experience of China and others. A new paper in Circulation illustrates how one group of cardiologists has been documenting what is known and unknown...

ADDITIONAL UPDATES

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

The COVID-19 pandemic is changing the way many physicians view the use of ACE inhibitors and angiotensin receptor blockers (ARBs), but experts caution against changing practice at this point given the lack of data showing any risk and stress that there is not enough evidence to suggest these medications can worsen COVID-19 morbidity and mortality. Concern over these drugs grew out of observational Chinese research showing greater morbidity and mortality among patients with hypertension who develop...

Cardiac Injury in COVID-19 Sharply Increases Risk of Death

Wuhan researchers have published details on 416 hospitalized patients, but treatment pathways remain unclear. New data out of Wuhan, China, confirm that cardiac injury is common in patients hospitalized with COVID-19 and, unsurprisingly, is tightly linked to higher mortality. One in five patients had cardiac injury; among those who did, half died, Shaobo Shi, MD (Renmin Hospital of Wuhan University, China), reports in JAMA Cardiology. Journal Reference: Shi S, Qin M, Shen B, et al. Association of...

Washington, District of Columbia
email: cmccullough@abcardio.org
Phone: 800-753-9222

Subscribe to ABC Clinical Updates & Insights

*Email:
*First Name:
*Last Name:
*Company:
Title:
Street Address:
City:
State / Province:
Zip / Postal Code:
Country:
Privacy Policy